Salus Pro Matches Illumina Platform in Targeted Clinical Sequencing Validation Study
A head-to-head evaluation demonstrated that the Salus Pro sequencing platform achieved comparable clinical performance to the Illumina NextSeq 550Dx across ...
A head-to-head evaluation demonstrated that the Salus Pro sequencing platform achieved comparable clinical performance to the Illumina NextSeq 550Dx across ...
A multicountry study reveals significant diagnostic delays and high healthcare utilization in patients with hereditary ATTR amyloidosis, highlighting the need ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.